By Nate Raymond

(Reuters) -Three Republican-led states have moved to broaden their lawsuit seeking to restrict access to the abortion pill mifepristone, aiming to block the U.S. Food and Drug Administration’s recent approval of a new generic version.

Missouri Attorney General Catherine Hanaway on Thursday said her state, along with Kansas and Idaho, is challenging the FDA’s September 30 approval of Evita Solutions’ generic version.

That regulatory decision by an agency now overseen by Republican President Donald Trump’s administration has fueled outrage among conservatives. Hanaway in a statement said the FDA “needs to stop rubber-stamping new mail-order generic versions.”

It was the second generic version of Danco Laboratories’ mifepristone to receive FDA approval. U.S. Health Secreta

See Full Page